1,543
Views
10
CrossRef citations to date
0
Altmetric
Report

Target-mediated drug disposition and prolonged liver accumulation of a novel humanized anti-CD81 monoclonal antibody in cynomolgus monkeys

, , , , , , , , , , , , & show all
Pages 776-786 | Received 08 Jun 2013, Accepted 05 Jul 2013, Published online: 08 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Charlotte Bon, Thomas Hofer, Alain Bousquet-Mélou, Mark R. Davies & Ben-Fillippo Krippendorff. (2017) Capacity limits of asialoglycoprotein receptor-mediated liver targeting. mAbs 9:8, pages 1360-1369.
Read now
Alexander Bujotzek, Florian Lipsmeier, Seth F Harris, Jörg Benz, Andreas Kuglstatter & Guy Georges. (2016) VH-VL orientation prediction for antibody humanization candidate selection: A case study. mAbs 8:2, pages 288-305.
Read now

Articles from other publishers (8)

Christian Bailly & Xavier Thuru. (2023) Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases. Cancers 15:7, pages 2186.
Crossref
Thanawat Suwatthanarak, Kei Usuba, Kotomi Kuroha, Masayoshi Tanaka & Mina Okochi. (2023) Screening of EWI-2-Derived Peptides for Targeting Tetraspanin CD81 and Their Effect on Cancer Cell Migration. Biomolecules 13:3, pages 510.
Crossref
Shen Cheng, Darcy R. Flora, Allan E. Rettie, Richard C. Brundage & Timothy S. Tracy. (2022) Pharmacokinetic Modeling of Warfarin І – Model-Based Analysis of Warfarin Enantiomers with a Target Mediated Drug Disposition Model Reveals CYP2C9 Genotype-Dependent Drug-Drug Interactions of S-Warfarin . Drug Metabolism and Disposition 50:9, pages 1287-1301.
Crossref
Wang Zheng, Qianping Chen, Hongxia Liu, Songling Hu, Yuchuan Zhou, Yang Bai, Jianghong Zhang, Yan Pan & Chunlin Shao. (2021) CD81 Enhances Radioresistance of Glioblastoma by Promoting Nuclear Translocation of Rad51. Cancers 13:9, pages 1998.
Crossref
Kenta Haraya, Tatsuhiko Tachibana & Tomoyuki Igawa. (2019) Improvement of pharmacokinetic properties of therapeutic antibodies by antibody engineering. Drug Metabolism and Pharmacokinetics 34:1, pages 25-41.
Crossref
Andrew T. Lucas, Ryan Robinson, Allison N. Schorzman, Joseph A. Piscitelli, Juan F. Razo & William C. Zamboni. (2019) Pharmacologic Considerations in the Disposition of Antibodies and Antibody-Drug Conjugates in Preclinical Models and in Patients. Antibodies 8:1, pages 3.
Crossref
Felipe Vences-CatalánCaroline DuaultChiung-Chi KuoRanjani RajapaksaRonald LevyShoshana Levy. (2017) CD81 as a tumor target. Biochemical Society Transactions 45:2, pages 531-535.
Crossref
P Dua, E Hawkins & PH van der Graaf. (2015) A Tutorial on Target-Mediated Drug Disposition (TMDD) Models. CPT: Pharmacometrics & Systems Pharmacology 4:6, pages 324-337.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.